An exploration of the early discharge approach for low-risk STEMI patients following primary percutaneous coronary intervention.
STEMI
early discharge strategy
length of stay
primary PCI
Journal
American journal of cardiovascular disease
ISSN: 2160-200X
Titre abrégé: Am J Cardiovasc Dis
Pays: United States
ID NLM: 101569582
Informations de publication
Date de publication:
2023
2023
Historique:
received:
07
11
2022
accepted:
17
03
2023
medline:
22
5
2023
pubmed:
22
5
2023
entrez:
22
5
2023
Statut:
epublish
Résumé
Recently, there has been growing interest in the early discharge strategy for low-risk patients who have undergone primary percutaneous coronary intervention (PCI) to treat ST-segment elevation myocardial infarction (STEMI). So far findings have suggested there are multiple advantages of shorter hospital stays, including that it could be a safe way to be more cost- and resource-efficient, reduce cases of hospital-acquired infection and boost patient satisfaction. However, there are remaining concerns surrounding safety, patient education, adequate follow-up and the generalisability of the findings from current studies which are mostly small-scale. By assessing the current research, we describe the advantages, disadvantages and challenges of early hospital discharge for STEMI and discuss the factors that determine if a patient can be considered low risk. If it is feasible to safely employ a strategy like this, the implications for healthcare systems worldwide could be extremely beneficial, particularly in lower-income economies and when we consider the detrimental impacts of the recent COVID-19 pandemic on healthcare systems.
Types de publication
Journal Article
Review
Langues
eng
Pagination
32-42Informations de copyright
AJCD Copyright © 2023.
Déclaration de conflit d'intérêts
None.
Références
J Am Coll Cardiol. 2021 Dec 21;78(25):2550-2560
pubmed: 34915986
Am Heart J. 2010 Jan;159(1):117.e1-6
pubmed: 20102876
J Am Heart Assoc. 2020 Jun 2;9(11):e015503
pubmed: 32468933
Circulation. 2004 Jun 8;109(22):2737-43
pubmed: 15159293
J Am Heart Assoc. 2020 Jun 16;9(12):e015186
pubmed: 32500800
N Engl J Med. 2000 Mar 16;342(11):749-55
pubmed: 10717009
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
Cardiovasc Revasc Med. 2020 Nov;21(11):1360-1368
pubmed: 32473910
Appl Nurs Res. 2021 Oct;61:151488
pubmed: 34544571
Nat Rev Dis Primers. 2019 Jun 6;5(1):39
pubmed: 31171787
Curr Opin Crit Care. 2009 Jun;15(3):234-8
pubmed: 19387339
Eur J Prev Cardiol. 2018 May;25(8):807-815
pubmed: 29537296
Can J Cardiol. 2020 Nov;36(11):1826-1829
pubmed: 32841675
Catheter Cardiovasc Interv. 2021 May 1;97(6):1120-1126
pubmed: 32649037
Am J Cardiol. 2019 Jun 1;123(11):1806-1811
pubmed: 30910227
Am Heart J. 2016 Nov;181:52-59
pubmed: 27823693
Glob Heart. 2021 Jul 01;16(1):46
pubmed: 34381668
Catheter Cardiovasc Interv. 2016 Jun;87(7):1194-200
pubmed: 26332101
J Am Heart Assoc. 2020 Jun 2;9(11):e016832
pubmed: 32468898
Scand Cardiovasc J. 2005 Oct;39(5):276-85
pubmed: 16269397
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Ir J Med Sci. 2020 Aug;189(3):873-884
pubmed: 31853738
J Am Coll Cardiol. 2005 May 3;45(9):1397-405
pubmed: 15862409
EuroIntervention. 2022 Jan 28;17(13):1091-1099
pubmed: 34338642
Arch Intern Med. 2011 Mar 28;171(6):559-67
pubmed: 21444846
Cureus. 2020 Dec 21;12(12):e12209
pubmed: 33489617
Kardiol Pol. 2021;79(9):988-994
pubmed: 34231873
Am J Cardiol. 2004 Mar 1;93(5):629-32
pubmed: 14996596
J Intern Med. 2010 Jul;268(1):40-9
pubmed: 20210836
Open Heart. 2015 Jun 24;2(1):e000235
pubmed: 26196017
Cardiol J. 2011;18(4):378-84
pubmed: 21769818
PLoS One. 2016 Aug 23;11(8):e0161493
pubmed: 27551861
Int Heart J. 2008 Nov;49(6):653-9
pubmed: 19075481
Eur Heart J. 2003 Jan;24(2):182-9
pubmed: 12573275
Am J Cardiovasc Dis. 2018 Oct 15;8(4):43-47
pubmed: 30498623
Indian Heart J. 2022 Jan-Feb;74(1):28-33
pubmed: 34864019
BMC Cardiovasc Disord. 2020 Aug 27;20(1):391
pubmed: 32854618
Am Heart J. 2016 Mar;173:57-66
pubmed: 26920597
Eur Heart J Qual Care Clin Outcomes. 2022 May 5;8(3):229-231
pubmed: 34951919